Professional
Added to YB: 2025-07-25
Pitch date: 2025-07-23
REGN [bullish]
Regeneron Pharmaceuticals, Inc.
+29.83%
current return
Author Info
The Superinvestors of Augustusville runs a small family office and shares pitches for their investments. Sign up for their newsletter.
Company Info
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Market Cap
$80.0B
Pitch Price
$570.96
Price Target
N/A
Dividend
0.45%
EV/EBITDA
14.60
P/E
18.76
EV/Sales
4.49
Sector
Biotechnology
Category
turnaround
Summer 2025 Update and thoughts on positions - Regeneron Pharmaceuticals, Inc.
REGN (new position): Stable biotech down >50% in a year, has 2 blockbuster drugs (Eylea, Dupixant), strong profitability, 15bn net cash (25% market cap) for buybacks, pipeline upside. History of profitable growth + high ROC. Entered at $520 despite some risks. Not highest conviction but decent bet.
Read full article (1 min)